5Floege J, Ostendorf T, Janssen U, et al.Novel approach to specific growth factor inhibition in vlvo: antag~sm of platelet-derived growth factor in glomerulonephritis by aptamers[J].Am J Pathol,1999, 54:169-179.
6Akagi Y, Isaka Y, Arai M, et al. Inhibition of TGF- [ beta ] 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis [J]. Kidney Int, 1996, 50:148 - 155.
7Isaka Y, Tsujle M, Ando Y, et al. Transforming growth factor- [ beta] 1 antisense oligonucleotides block interstitial fibrosis in unilateral ureteral obstruction [J]. Kidney Int,2000, 58:1885- 1892.
8Tomita N, Morlshita R, Lan H, et al. In vivo administration of a nuclear transcription factor -kappa-B decoy suppresses experimental crescentic glomerulonephritis[J]. J Am Soc Nephrol, 2000, 11:1244-1252.
9Clar kMA, Plank LD, Connolly AB, et al.Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic respomes in patients with severe sepsis: a randomized, clinical trial [J]. Crit Care Med,1998, 26:1650 - 1659.
10Van Dullemen HM, van Deventer SJ, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor nectosis factor chimeric monoclonal antibody (cA2)[J].Gastroenterology, 1995, 109:129-135.
